The story of Viagra and its effect on the healthcare industry presents a challenging picture for investors . While the initial blockbuster status of the drug's flagship product generated substantial gains, https://idamcgb583434.bloggadores.com/39810821/the-little-blue-pill-and-drug-companies-a-potentially-problematic-venture